Top

Antimicrobial Resistance & Infection Control

Published in:

Open Access 01-12-2018 | Review

Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries

Authors: Gabriel Birgand, Enrique Castro-Sánchez, Sonja Hansen, Petra Gastmeier, Jean-Christophe Lucet, Ewan Ferlie, Alison Holmes, Raheelah Ahmad

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2018

Abstract

Policy makers and governments are calling for coordination to address the crisis emerging from the ineffectiveness of current antibiotics and stagnated pipe-line of new ones – antimicrobial resistance (AMR). Wider contextual drivers and mechanisms are contributing to shifts in governance strategies in health care, but are national health system approaches aligned with strategies required to tackle antimicrobial resistance? This article provides an analysis of governance approaches within healthcare systems including: priority setting, performance monitoring and accountability for AMR prevention in three European countries: England, France and Germany. Advantages and unresolved issues from these different experiences are reported, concluding that mechanisms are needed to support partnerships between healthcare professionals and patients with democratized decision-making and accountability via collaboration. But along with this multi-stakeholder approach to governance, a balance between regulation and persuasion is needed.

Hoffman SJ, Caleo GM, Daulaire N, Elbe S, Matsoso P, Mossialos E, et al. Strategies for achieving global collective action on antimicrobial resistance. Bull World Health Organ. 2015;93:867–76.CrossRefPubMedPubMedCentral

Jim O’Neill’s. Tackling drug-resistant infections globally: final report and recommendations [Internet]. Available from: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf. Accessed 6^th Feb 2018.

Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet Lond Engl. 2016;387:296–307.CrossRef

Nuti S, Vola F, Bonini A, Vainieri M. Making governance work in the health care sector: evidence from a “natural experiment” in Italy. Health Econ Policy Law. 2015:1–22.

Smith PC, Anell A, Busse R, Crivelli L, Healy J, Lindahl AK, et al. Leadership and governance in seven developed health systems. Health Policy Amst Neth. 2012;106:37–49.CrossRef

World Health Organisation. Strategic and Technical Advisory Group on Antimicrobial Resistance (STAG-AMR) [Internet]. 2014. Available from: http://apps.who.int/iris/bitstream/10665/128675/1/WHO_HSE_PED_AIP_2014.4_eng.pdf. Accessed 6^th Feb 2018.

D’Angeli MA, Baker JB, Call DR, Davis MA, Kauber KJ, Malhotra U, et al. Antimicrobial stewardship through a one health lens: Observations from Washington State. Int J Health. 2016;Gov:114–30. ISSN: 2059-4631.

Dar OA, Hasan R, Schlundt J, Harbarth S, Caleo G, Dar FK, et al. Exploring the evidence base for national and regional policy interventions to combat resistance. Lancet Lond Engl. 2016;387:285–95.CrossRef

Department of Health. What is a healthcare associated infection? [Internet]. 2012. Available from: http://webarchive.nationalarchives.gov.uk/20120118164404/http://hcai.dh.gov.uk/reducinghcais/hcai/. Accessed 6^th Feb 2018.

10.

Gill M. Building Effective Approaches to Governance [Internet]. 2002. Available from: https://nonprofitquarterly.org/governancevoice/113-building-effective-approaches-to-governance.html. Accessed 6^th Feb 2018.

11.

World Health Organisation. Strategizing national health in the 21st century: a handbook [Internet]. Available from: http://www.who.int/healthsystems/publications/nhpsp-handbook/en/. Accessed 6^th Feb 2018.

12.

Bullivant J, Burgess R, Corbett-Nolan A, Godfrey K. Goog Governance Handbook. 2012. Available from: https://www.good-governance.org.uk/wp-content/uploads/2017/04/Good-Governance-Handbook.pdf. Accessed 6^th Feb 2018.

13.

Washer P, Joffe H. The “hospital superbug”: social representations of MRSA. Soc Sci Med. 2006;63:2141–52.CrossRefPubMed

14.

Bell SK, White AA, Yi JC, Yi-Frazier JP, Gallagher TH. Transparency When Things Go Wrong: Physician Attitudes About Reporting Medical Errors to Patients, Peers, and Institutions. J Patient Saf. 2015;

15.

Dixon-Woods M, Bosk CL, Aveling EL, Goeschel CA, Pronovost PJ. Explaining Michigan: developing an ex post theory of a quality improvement program. Milbank Q. 2011;89:167–205.CrossRefPubMedPubMedCentral

16.

Stephen C, Stemshorn B. Leadership, governance and partnerships are essential One Health competencies. One Health. 2016:161–3.

17.

Bovens M. The quest for responsibility: Accountability and citizenship in complex organizations. Cambridge university press. 1998;

18.

WHO/Europe. ]Governance for health in the 21st century [Internet]. 2012. Available from: http://www.euro.who.int/__data/assets/pdf_file/0019/171334/RC62BD01-Governance-for-Health-Web.pdf. Accessed 6^th Feb 2018.

19.

Duerden B. Biology, politics and performance management: tackling healthcare-associated infections in the NHS in England. Clinical risk. 2010:169–72.

20.

Health foundation. Healthcare-associated infections, spotlight report [Internet]. 2015. Available from: http://www.health.org.uk/sites/health/files/InfectionPreventionAndControlLessonsFromAcuteCareInEngland.pdf. Accessed 6^th Feb 2018.

21.

Hansen S, Zingg W, Ahmad R, Kyratsis Y, Behnke M, Schwab F, et al. Organization of infection control in European hospitals. J Hosp Infect. 2015;91:338–45.CrossRefPubMed

22.

Hood C. The “New Public Management” in the 1980s: variations on a theme. Account Organ Soc. 1995;20:93–109.CrossRef

23.

Ferlie E, Ashburner L, FitzGerald PA. The new public management in action. Oxford Scholarship Online: Oxford University Press; 2011.

24.

Newman J. Modernising Governance. London: Sage; 2001.

25.

Cookson B, Roberts J. The management prevention and control of healthcare associated infections in acute NHS trusts in England - International comparison and review. 2009;

26.

Kyratsis Y, Ahmad R, Hatzaras K, Iwami M, Holmes A. Making sense of evidence in management decisions: the role of research-based knowledge on innovation adoption and implementation in health care [Internet]. Southampton: NIHR Journals Library; 2014 [cited 2015 Apr 7]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK259620/. Accessed 6^th Feb 2018.

27.

Van Der Wees PJ, Der Sanden MWG N-V, Ayanian JZ, Black N, Westert GP, Schneider EC. Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries. Milbank Q. 2014;92:754–75.CrossRefPubMedPubMedCentral

28.

Brewster L, Tarrant C, Dixon-Woods M. Qualitative study of views and experiences of performance management for healthcare-associated infections. J Hosp Infect. 2016;

29.

Hughes V. Europe pledges billions to solve its drug development woes [Internet]. Nat Med; 2008. Available from: http://www.nature.com/nm/journal/v14/n2/full/nm0208-107.html. Accessed 6^th Feb 2018.

30.

Ramsay A, Magnusson C, Fulop N. The relationship between external and local governance systems: the case of health care associated infections and medication errors in one NHS trust. Qual Saf Health Care. 2010;19:e45.PubMed

31.

Department of Health. UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018 [Internet]. 2013. Available from: https://www.gov.uk/government/publications/uk-5-year-antimicrobial-resistance-strategy-2013-to-2018. Accessed 6^th Feb 2018.

32.

Department of Health. The NHS in England: The Operating Framework for 2008/09. [Internet]. 2007. Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_081271.pdf. Accessed 6^th Feb 2018.

33.

Department of Health. The Chief Medical Officer (CMO), Professor Dame Sally Davies’s report on the threat of antimicrobial resistance and infectious diseases. [Internet]. 2013. Available from: https://www.gov.uk/government/publications/chief-medical-officer-annual-report-volume-2. Accessed 6^th Feb 2018.

34.

Public Health England. The government mandate clearly specified the need to support the goal to established global and UK baseline and ambition to prevent AMR. [Internet]. 2015. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/494485/NHSE_mandate_16-17_22_Jan.pdf. Accessed 6^th Feb 2018.

35.

NHS Commissioning Board. NHS Commissioning Board. Everyone counts: planning for patients 2013/14. [Internet]. 2012. Available from: https://www.england.nhs.uk/2012/12/everyonecounts/. Accessed 6^th Feb 2018.

36.

Public Health England. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report [Internet]. 2017. Available from: https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report. Accessed 6^th Feb 2018.

37.

NHS England. NHS Standard Contract 2014/15 Particulars. [Internet]. 2013. Available from: https://www.england.nhs.uk/nhs-standard-contract/14-15/. Accessed 6^th Feb 2018.

38.

Public Health England. AMR local indicators [Internet]. 2016. Available from: http://fingertips.phe.org.uk/profile/amr-local-indicators. Accessed 6^th Feb 2018.

39.

Touraine M. Tackling antimicrobial resistance in France. Lancet Lond Engl. 2016;387(10034):2177–9.CrossRef

40.

Ministère des affaires sociales, de la santé et des droits des femmes. Programme national d’actions de prévention des infections associées aux soins - Propias [Internet]. 2015. Available from: http://www.sante.gouv.fr/IMG/pdf/PropiasJuin2015.pdf. Accessed 6^th Feb 2018.

41.

Carbonne A, Arnaud I, Maugat S, Marty N, Dumartin C, Bertrand X, et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J Antimicrob Chemother. 2013;68:954–9.CrossRefPubMed

42.

Dumartin C, Rogues A-M, Amadeo B, Pefau M, Venier A-G, Parneix P, et al. Antibiotic stewardship programmes: legal framework and structure and process indicator in Southwestern French hospitals, 2005-2008. J Hosp Infect. 2011;77:123–8.CrossRefPubMed

43.

MINISTÈRE DES AFFAIRES SOCIALES, DE LA SANTÉ, ET DES DROITS DES FEMMES. Instruction DGS/RI1/DGOS/PF2/DGCS no 2015-212 du 19 juin 2015 relative à la mise en œuvre de la lutte contre l’antibiorésistance sous la responsabilité des agences régionales de santé [Internet]. 2015. Available from: http://social-sante.gouv.fr/fichiers/bo/2015/15-08/ste_20150008_0000_0124.pdf. Accessed 6^th Feb 2018.

44.

Mielke M. Report of the third meeting of the coordinators of the regional MRP networks in Germany on 15 and 16 December 2011 at the Robert Koch Institute. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55:1474–82.CrossRefPubMed

45.

Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect. 2008;70(Suppl 1):11–6.CrossRefPubMed

46.

de With K, Allerberger F, Amann S, Apfalter P, Brodt H-R, Eckmanns T, et al. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection. 2016;

47.

Bekanntmachung des Robert Koch-Instituts. Festlegung der Daten zu Art und Umfang des Antibiotikaverbrauchs in Krankenhäusern nach § 23 Abs. 4 Satz 2 IfSG. Bundesgesundheitsbl. 2013;56:996–1002.

48.

Schweickert B, Kern WV, de With K, Meyer E, Berner R, Kresken M, et al. Surveillance of antibiotic consumption : clarification of the “definition of data on the nature and extent of antibiotic consumption in hospitals according to § 23 paragraph 4 sentence 2 of the IfSG”. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:903–12.CrossRefPubMed

49.

Schröder C, Schwab F, Behnke M, Breier A-C, Maechler F, Piening B, et al. Epidemiology of healthcare associated infections in Germany: Nearly 20 years of surveillance. Int J Med Microbiol IJMM. 2015;305:799–806.CrossRefPubMed

50.

van Cleef BAGL, Kluytmans JAJW, van Benthem BHB, Haenen A, Monen J, Daniels-Haardt I, et al. Cross border comparison of MRSA bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): a cross-sectional study. PloS One. 2012;7:e42787.CrossRefPubMedPubMedCentral

51.

Busse A, Riesberg R. Healthcare Systems in Transition: Germany. WHO Regional Office forEurope on behalf of the European Observatory on Health Systems and Policies.: Copenhagen; 2004.

52.

Lisac M, Reimers L, Henke K, Schlette S. Access and Choice - Competition under the Roof of Solidarity in German Health Care: An Analysis of Health Policy Reforms since 2004. Health Econ Policy Law. 2010;5:p. 31–53.

53.

G8 science ministers written statement from their UK meeting on international issues that need global cooperation [Internet]. 2013. Available from: https://www.gov.uk/government/publications/g8-science-ministers-statement-london-12-june-2013. Accessed 6^th Feb 2018.

54.

Kickbusch I, Buckett K. Health in all policies: the evolution of the concept of horizontal health governance,. Implement Health Policies [Internet]. Adelaide; 2010. Available from: http://www.who.int/sdhconference/resources/implementinghiapadel-sahealth-100622.pdf. Accessed 6^th Feb 2018.

55.

McQuaid R. Theory of organizational partnerships: partnership advantages, disadvantages and success factors. New Public Gov Emerg Perspect Theory Pract Public Gov. Osborne SP. London: Routledge; 2009.

56.

Employment, Social policy, Health and Consumer affairs Council meeting. Council conclusions on patient safety and quality of care, including the prevention and control of healthcare associated infections and antimicrobial resistance [Internet]. 2014. Available from: http://www.consilium.europa.eu/en/press/press-releases/2016/06/17/epsco-conclusions-antimicrobial-resistance/. Accessed 6^th Feb 2018.

57.

Coulter A. What do patients and the public want from primary care? BMJ. 2005;331:1199–201.CrossRefPubMedPubMedCentral

58.

Eysenbach G. Infodemiology: tracking flu-related searches on the web for syndromic surveillance. AMIA Annu Symp Proc. 2006:244–8. https://www.ncbi.nlm.nih.gov/pubmed/17238340.

59.

Franko OI, Tirrell TF. Smartphone app use among medical providers in ACGME training programs. J Med Syst. 2012;36:3135–9.CrossRefPubMed

60.

National Institute for Health and Care Excellence. Patient and public involvement policy. [Internet]. Available from: https://www.nice.org.uk/about/nice-communities/public-involvement/patient-and-public-involvement-policy. Accessed 6^th Feb 2018.

61.

The Council of the European Union. Recommendation on the Prudent Use of Antimicrobial Agents in Human Medicine (2002/77/EC).

62.

Plachouras D, Kavatha D, Antoniadou A, Giannitsioti E, Poulakou G, Kanellakopoulou K, et al. Dispensing of antibiotics without prescription in Greece, 2008: another link in the antibiotic resistance chain. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2010;15:7.

63.

Thaler RH, Sunstein CR. Nudge: Improving decisions about health, wealth, and happiness. New Haven, CT: Yale University Press; 2008.

64.

Perry C, Chhatralia K, Damesick D, Hobden S, Volpe L. Behavioural insights in health care [Internet]. 2015. Available from: http://www.health.org.uk/sites/health/files/BehaviouralInsightsInHealthCare.pdf

65.

Mossialos E, Permanand G, Baeten R, Hervey TK. Health systems governance in Europe: the role of European Union law and policy: Cambridge University Press; 2010.

66.

Beck U. Risk society: Towards a new modernity. London: Sage; 1992.

67.

Scott LA, Maddux PT, Schnellmann J, Hayes L, Tolley J, Wahlquist AE. High-fidelity multiactor emergency preparedness training for patient care providers. Am J Disaster Med. 2012;7:175–88.CrossRefPubMedPubMedCentral

68.

Hood C, Rothstein H, Baldwin R. The Government of Risk: Understanding Risk Regulation Regimes. Oxford: Oxford Scholarship Online; 2003.

Title: Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries
Authors: Gabriel Birgand
Enrique Castro-Sánchez
Sonja Hansen
Petra Gastmeier
Jean-Christophe Lucet
Ewan Ferlie
Alison Holmes
Raheelah Ahmad
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Antimicrobial Resistance & Infection Control / Issue 1/2018
Electronic ISSN: 2047-2994
DOI: https://doi.org/10.1186/s13756-018-0321-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Temporal relationship between antibiotic use and respiratory virus activities in the Republic of Korea: a time-series analysis

In vitro activity of ivermectin against Staphylococcus aureus clinical isolates

Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Letter to the editor in response to estimating the burden of antimicrobial resistance: a systematic literature review

APSIC guidelines for disinfection and sterilization of instruments in health care facilities

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page